Kangstem Biotech Co., Ltd. (KOSDAQ:217730)
2,010.00
+41.00 (2.08%)
At close: Mar 6, 2026
Kangstem Biotech Market Cap
Kangstem Biotech has a market cap or net worth of 189.05 billion as of March 6, 2026. Its market cap has increased by 68.63% in one year.
Market Cap
189.05B
Enterprise Value
170.84B
Revenue
12.77B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,010.00
Market Cap Chart
Since December 21, 2015, Kangstem Biotech's market cap has increased from 129.33B to 189.05B, an increase of 46.18%. That is a compound annual growth rate of 3.79%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ensol Biosciences | 191.01B |
| QuadMedicine | 186.24B |
| TiumBio | 197.44B |
| Prestige Biologics | 202.16B |
| ISU Abxis | 206.04B |
| Genome & Company | 245.30B |
| ABION | 259.94B |
| Bio Solution | 281.61B |